These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
382 related items for PubMed ID: 23223857
21. Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors. Singh R, Pantarotto D, McCarthy D, Chaloin O, Hoebeke J, Partidos CD, Briand JP, Prato M, Bianco A, Kostarelos K. J Am Chem Soc; 2005 Mar 30; 127(12):4388-96. PubMed ID: 15783221 [Abstract] [Full Text] [Related]
22. Higher dispersion efficacy of functionalized carbon nanotubes in chemical and biological environments. Heister E, Lamprecht C, Neves V, Tîlmaciu C, Datas L, Flahaut E, Soula B, Hinterdorfer P, Coley HM, Silva SR, McFadden J. ACS Nano; 2010 May 25; 4(5):2615-26. PubMed ID: 20380453 [Abstract] [Full Text] [Related]
23. Stimulation of neuronal neurite outgrowth using functionalized carbon nanotubes. Matsumoto K, Sato C, Naka Y, Whitby R, Shimizu N. Nanotechnology; 2010 Mar 19; 21(11):115101. PubMed ID: 20173239 [Abstract] [Full Text] [Related]
24. The devil and holy water: protein and carbon nanotube hybrids. Calvaresi M, Zerbetto F. Acc Chem Res; 2013 Nov 19; 46(11):2454-63. PubMed ID: 23826731 [Abstract] [Full Text] [Related]
25. Two faces of carbon nanotube: toxicities and pharmaceutical applications. Gulati N, Gupta H. Crit Rev Ther Drug Carrier Syst; 2012 Nov 19; 29(1):65-88. PubMed ID: 22356722 [Abstract] [Full Text] [Related]
26. PEG-modified carbon nanotubes in biomedicine: current status and challenges ahead. Bottini M, Rosato N, Bottini N. Biomacromolecules; 2011 Oct 10; 12(10):3381-93. PubMed ID: 21916410 [Abstract] [Full Text] [Related]
27. Carbon nanotubes as functional excipients for nanomedicines: I. Pharmaceutical properties. Foldvari M, Bagonluri M. Nanomedicine; 2008 Sep 10; 4(3):173-82. PubMed ID: 18550451 [Abstract] [Full Text] [Related]
28. Asymmetrically charged carbon nanotubes by controlled functionalization. Peng Q, Qu L, Dai L, Park K, Vaia RA. ACS Nano; 2008 Sep 23; 2(9):1833-40. PubMed ID: 19206422 [Abstract] [Full Text] [Related]
29. Synthesis of cycloparaphenylenes and related carbon nanorings: a step toward the controlled synthesis of carbon nanotubes. Omachi H, Segawa Y, Itami K. Acc Chem Res; 2012 Aug 21; 45(8):1378-89. PubMed ID: 22587963 [Abstract] [Full Text] [Related]
30. Applications of carbon nanotubes in neurobiology. Malarkey EB, Parpura V. Neurodegener Dis; 2007 Aug 21; 4(4):292-9. PubMed ID: 17627132 [Abstract] [Full Text] [Related]
31. Applications of carbon nanotubes-based biomaterials in biomedical nanotechnology. Polizu S, Savadogo O, Poulin P, Yahia L. J Nanosci Nanotechnol; 2006 Jul 21; 6(7):1883-904. PubMed ID: 17025102 [Abstract] [Full Text] [Related]
32. [Functionalization of carbon nanotubes for multimodal drug delivery]. Mielcarek J, Skupin P. Przegl Lek; 2011 Jul 21; 68(3):167-70. PubMed ID: 21812234 [Abstract] [Full Text] [Related]
33. Carbon nanotubes for biomedical applications. Sinha N, Yeow JT. IEEE Trans Nanobioscience; 2005 Jun 21; 4(2):180-95. PubMed ID: 16117026 [Abstract] [Full Text] [Related]
34. Carbon nanotube applications for tissue engineering. Harrison BS, Atala A. Biomaterials; 2007 Jan 21; 28(2):344-53. PubMed ID: 16934866 [Abstract] [Full Text] [Related]
35. Functionalization of carbon nanotubes: manufacturing techniques and properties of customized nanocomponents for molecular-level technology. Akbar S, Taimoor AA. Recent Pat Nanotechnol; 2009 Jan 21; 3(2):154-61. PubMed ID: 19519597 [Abstract] [Full Text] [Related]
36. Elucidation of the role of carbon nanotube patterns on the development of cultured neuronal cells. Béduer A, Seichepine F, Flahaut E, Loubinoux I, Vaysse L, Vieu C. Langmuir; 2012 Dec 18; 28(50):17363-71. PubMed ID: 23190396 [Abstract] [Full Text] [Related]
37. Polymeric composites containing carbon nanotubes for bone tissue engineering. Sahithi K, Swetha M, Ramasamy K, Srinivasan N, Selvamurugan N. Int J Biol Macromol; 2010 Apr 01; 46(3):281-3. PubMed ID: 20093139 [Abstract] [Full Text] [Related]
38. Interfacing carbon nanotubes with living mammalian cells and cytotoxicity issues. Cui HF, Vashist SK, Al-Rubeaan K, Luong JH, Sheu FS. Chem Res Toxicol; 2010 Jul 19; 23(7):1131-47. PubMed ID: 20402485 [Abstract] [Full Text] [Related]
39. Multifunctional hybrid-carbon nanotubes: new horizon in drug delivery and targeting. Mehra NK, Jain NK. J Drug Target; 2016 Jul 19; 24(4):294-308. PubMed ID: 26147085 [Abstract] [Full Text] [Related]
40. Soluble carbon nanotubes and their applications. Murakami H, Nakashima N. J Nanosci Nanotechnol; 2006 Jan 19; 6(1):16-27. PubMed ID: 16573065 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]